➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Boehringer Ingelheim
Johnson and Johnson
Dow
AstraZeneca

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Patent: 9,987,356

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,987,356
Title:Anti-CD40 antibodies and methods of administering thereof
Abstract: The present invention relates to antibodies specific for a particular epitope on CD40 and antibodies that bind CD40 and have particular functional characteristics. The present invention also relates to fragments of these antibodies, uses of the antibodies for reduction or treatment of transplant rejection and graft-versus-host disease, and methods for making the antibodies.
Inventor(s): Reimann; Keith A. (Marblehead, MA), Wang; Rijian (Saugus, MA), Larsen; Christian P. (Atlanta, GA)
Assignee: Beth Israel Deaconess Medical Center, Inc. (Boston, MA) Emory University (Atlanta, GA)
Application Number:14/004,552
Patent Claims:see list of patent claims

Details for Patent 9,987,356

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 002 2017-06-22   Start Trial Beth Israel Deaconess Medical Center, Inc. (Boston, MA) Emory University (Atlanta, GA) 2031-03-11 RX Orphan search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 001 2017-06-22   Start Trial Beth Israel Deaconess Medical Center, Inc. (Boston, MA) Emory University (Atlanta, GA) 2031-03-11 RX Orphan search
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2017-05-26   Start Trial Beth Israel Deaconess Medical Center, Inc. (Boston, MA) Emory University (Atlanta, GA) 2031-03-11 RX search
Bristol Myers Squibb NULOJIX belatacept INJECTABLE; INJECTION 125288 001 2011-06-15   Start Trial Beth Israel Deaconess Medical Center, Inc. (Boston, MA) Emory University (Atlanta, GA) 2031-03-11 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Harvard Business School
Dow
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.